OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!
If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.
Requested Article:
Disease activity indices in psoriatic arthritis: current and evolving concepts
Chrysoula G. Gialouri, G. Fragoulis
Clinical Rheumatology (2021) Vol. 40, Iss. 11, pp. 4427-4435
Closed Access | Times Cited: 13
Chrysoula G. Gialouri, G. Fragoulis
Clinical Rheumatology (2021) Vol. 40, Iss. 11, pp. 4427-4435
Closed Access | Times Cited: 13
Showing 13 citing articles:
Effect of body mass index on treatment response of biologic/targeted-synthetic DMARDs in patients with rheumatoid arthritis, psoriatic arthritis or axial spondyloarthritis. A systematic review
Chrysoula G. Gialouri, Μαρία Παππά, Gerasimos Evangelatos, et al.
Autoimmunity Reviews (2023) Vol. 22, Iss. 7, pp. 103357-103357
Closed Access | Times Cited: 28
Chrysoula G. Gialouri, Μαρία Παππά, Gerasimos Evangelatos, et al.
Autoimmunity Reviews (2023) Vol. 22, Iss. 7, pp. 103357-103357
Closed Access | Times Cited: 28
The role of IL‐23 and the use of IL‐23 inhibitors in psoriatic arthritis
G. Fragoulis, Stefan Siebert
Musculoskeletal Care (2022) Vol. 20, Iss. S1
Open Access | Times Cited: 28
G. Fragoulis, Stefan Siebert
Musculoskeletal Care (2022) Vol. 20, Iss. S1
Open Access | Times Cited: 28
Phase 2 Trial of Deucravacitinib in Psoriatic Arthritis: Biomarkers Associated With Disease Activity, Pharmacodynamics, and Clinical Responses
Oliver FitzGerald, Dafna D. Gladman, Philip J. Mease, et al.
Arthritis & Rheumatology (2024) Vol. 76, Iss. 9, pp. 1397-1407
Open Access | Times Cited: 5
Oliver FitzGerald, Dafna D. Gladman, Philip J. Mease, et al.
Arthritis & Rheumatology (2024) Vol. 76, Iss. 9, pp. 1397-1407
Open Access | Times Cited: 5
Identification and characteristics of patients with potential difficult-to-treat psoriatic arthritis: exploratory analyses of the Greek PsA registry
Konstantinos D Vassilakis, Charalampos Papagoras, Nikolaos Fytanidis, et al.
Lara D. Veeken (2024) Vol. 63, Iss. 9, pp. 2427-2432
Open Access | Times Cited: 4
Konstantinos D Vassilakis, Charalampos Papagoras, Nikolaos Fytanidis, et al.
Lara D. Veeken (2024) Vol. 63, Iss. 9, pp. 2427-2432
Open Access | Times Cited: 4
The role of mediators in the formation of leading pathological processes in psoriatic arthritis
D. A. Pogonchenkova, L. V. Chetvernya, Olga A. Vasil'yeva, et al.
Bulletin of Siberian Medicine (2025) Vol. 23, Iss. 4, pp. 187-196
Open Access
D. A. Pogonchenkova, L. V. Chetvernya, Olga A. Vasil'yeva, et al.
Bulletin of Siberian Medicine (2025) Vol. 23, Iss. 4, pp. 187-196
Open Access
Normal C-reactive protein in active psoriatic arthritis: results from real-world clinical practice
Chrysoula G. Gialouri, Gerasimos Evangelatos, Μαρία Παππά, et al.
Therapeutic Advances in Musculoskeletal Disease (2022) Vol. 14
Open Access | Times Cited: 15
Chrysoula G. Gialouri, Gerasimos Evangelatos, Μαρία Παππά, et al.
Therapeutic Advances in Musculoskeletal Disease (2022) Vol. 14
Open Access | Times Cited: 15
Distinct innate and adaptive immunity phenotypic profile at the circulating single-cell level in Psoriatic Arthritis
G. Fragoulis, Eleni‐Kyriaki Vetsika, Maria Kyriakidi, et al.
Clinical Immunology (2023) Vol. 253, pp. 109679-109679
Closed Access | Times Cited: 6
G. Fragoulis, Eleni‐Kyriaki Vetsika, Maria Kyriakidi, et al.
Clinical Immunology (2023) Vol. 253, pp. 109679-109679
Closed Access | Times Cited: 6
Serum Calprotectin as a Promising Inflammatory Biomarker in Psoriatic Arthritis: a 1-Year Longitudinal Study
Borui Li, Guangtao Li, Zhibo Song, et al.
Rheumatology and Therapy (2022)
Open Access | Times Cited: 4
Borui Li, Guangtao Li, Zhibo Song, et al.
Rheumatology and Therapy (2022)
Open Access | Times Cited: 4
Comparison between methotrexate and apremilast in Psoriatic Arthritis-a single blind randomized controlled trial (APREMEPsA study)
Joydeep Samanta, Shankar Naidu, Arghya Chattopadhyay, et al.
Rheumatology International (2023) Vol. 43, Iss. 5, pp. 841-848
Open Access | Times Cited: 2
Joydeep Samanta, Shankar Naidu, Arghya Chattopadhyay, et al.
Rheumatology International (2023) Vol. 43, Iss. 5, pp. 841-848
Open Access | Times Cited: 2
“It’s Like Listening to the Radio with a Little Interference”: A Qualitative Study Describing Pain Management among Patients with Psoriatic Arthritis
Nina Brodin, Björn Sundström, Mathilda Björk, et al.
Journal of Clinical Medicine (2023) Vol. 12, Iss. 23, pp. 7348-7348
Open Access | Times Cited: 1
Nina Brodin, Björn Sundström, Mathilda Björk, et al.
Journal of Clinical Medicine (2023) Vol. 12, Iss. 23, pp. 7348-7348
Open Access | Times Cited: 1
Critical importance of patient-reported outcomes for a comprehensive assessment of psoriatic arthritis patients
Marika Lo Monaco, Raffaella Mallaci Bocchio, Giuseppe Natoli, et al.
Frontiers in Medicine (2024) Vol. 10
Open Access
Marika Lo Monaco, Raffaella Mallaci Bocchio, Giuseppe Natoli, et al.
Frontiers in Medicine (2024) Vol. 10
Open Access
Core items to be included in a definition of moderate psoriatic arthritis: literature review and expert opinion
Ana Urruticoechea‐Arana, José Luis Álvarez-Vega, María Luz García-Vivar, et al.
Rheumatology International (2024) Vol. 44, Iss. 11, pp. 2327-2336
Closed Access
Ana Urruticoechea‐Arana, José Luis Álvarez-Vega, María Luz García-Vivar, et al.
Rheumatology International (2024) Vol. 44, Iss. 11, pp. 2327-2336
Closed Access
Evaluation of the Disease Activity index for PSoriatic Arthritis (DAPSA) with a quick quantitative C reactive protein assay (Q-DAPSA) in patients with psoriatic arthritis: a prospective multicentre cross-sectional study
Fabian Proft, Julia Schally, H. Brandt, et al.
RMD Open (2022) Vol. 8, Iss. 2, pp. e002626-e002626
Open Access | Times Cited: 2
Fabian Proft, Julia Schally, H. Brandt, et al.
RMD Open (2022) Vol. 8, Iss. 2, pp. e002626-e002626
Open Access | Times Cited: 2
